tralokinumab
tralokinumab noun: a human monoclonal antibody targeting interleukin 13, designed for the treatment of asthma and inflammatory diseases.
Noun
tralokinumab (uncountable)
- A human monoclonal antibody targeting interleukin 13, designed for the treatment of asthma and inflammatory diseases.
Origin of tralokinumab
From -kin- (“interleukin”) + -umab (“human monoclonal antibody”).
Questions about tralokinumab
- What does tralokinumab mean?
- Tralokinumab means a human monoclonal antibody targeting interleukin 13, designed for the treatment of asthma and inflammatory diseases.
- What part of speech is tralokinumab?
- Tralokinumab is a noun.
Words near tralokinumab in the dictionary
Source and license
Adapted from Wiktionary: tralokinumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “tralokinumab.” Word.ws, https://word.ws/tralokinumab. Based on Wiktionary, CC BY-SA 4.0.
